Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea];Tratamento do glioblastoma recorrente com BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea] intra arterial

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 5, 2010, Pages 778-782

  Figueiredo, Eberval Gadelha ^a   de Faria, Jose Weber Vieira ^a,b   Teixeira, Manoel Jacobsen ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Carmustine; Carotid artery; Chemotherapy; Malignant gliomas; Ophthalmic artery

Indexed keywords

CARMUSTINE;

ADULT; AGED; ARTICLE; BLINDNESS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONFUSION; DETERIORATION; DISEASE COURSE; DRUG INDUCED HEADACHE; DRUG INFUSION; EYE PAIN; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; RECURRENT CANCER; REFERRED PAIN; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT;

EID: 78649509580     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/s0004-282x2010000500020     Document Type: Article

References (33)

1. Kraemer DF, Fortin D, Neuwelt EA. Chemotherapeutic dose intensification for treatment of malignant brain tumors: rrecent developments and future directions. Cur Neurol Neurosc Rep 2002;2:216-224.
2. Tatsuta T, Naito M, Oh-hara T, et al. Functional involvement of P-Glycoprotein in blood-brain barrier. J Biol Chem 1992;267:20383-20391.
3. Levin V. Pharmacological principles of brain tumor chemotherapy. In: Thompson R, Green J (Eds). Advances in neurology. New York: Raven Press 1976:315-325.
4. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Pattern of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-1409.
5. Deeken JF, Loscher W. The blood brain barrier and cancer: transports, treatment, and Trojan horses. Clin Cancer Res 2007;13:1663-1674.
6. Fortin D, Desjardins A, Benko A, et al. Enhanced chemotherapy delivery by intraarterial infusion and blood brain barrier disruption in malignant brain tumors: The Sherbrooke experience. Cancer 2005;103:2606-2615.
7. Moynihan T, Grossman S. The role of chemotherapy in the treatment of primary tumors of the central nervous system. Cancer Invest 1994;12:88-97.
8. Wheeler G, Bowdon B, Grimsley J, et al. Interrelationships of some chemical, physiochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Cancer Res 1974;34:194-200.
9. Newton H, Grahovac Z, Hugenholtz H, et al. Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurgery 1987;21: 207-214.
10. Dropcho EJ, Rosenfeld SS, Vitek J, et al. Phase II study of intracarotid or selective intracerebral infusion of cisplastin for treatment of recurrent anaplastic gliomas. J Neurooncol 1998;36:191-198.
11. Ashby LS, Shapiro WR. Intrarterial cisplatin plus oral ectoposide for the treatment of recurrent malignant gliomas: a phase II study. J Neurooncol 2001;51:67-86.
12. Madajewicz S, Chowhan N, Tfayli A, et al. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer 2000;88:2350-2356.
13. Shapiro W, Gree S, Burger P, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluoruracil, for newly diagnosed patients with malignant gliomas. J Neurosurg 1992; 76:772-781.
14. Green S, Byar D, Walker M, et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomas, Cancer Treat Rep 1983;67: 121-132.
15. DeAngelis L, Burger P, Green S, et al. Malignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol 1998;44:691-695.
16. Shapiro W. Therapy of adulto malignant brain tumrors: what have the clinical trials taught us? Semin Oncol 1986;13:38-45.
17. Fine H, Dear K, Loeffler J, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-2597.
18. Stewart LA. Chemotherapy in adult high-grade gliomas: a systematic review and meta-analysis of individual patient data from 12 randomised trials.Lancet 2002;359:1011-1018.
19. Greenberg HS, Ensminger WD, Chandler WF, et al. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 1984;61:423-429.
20. Collins J. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984;2:498-504.
21. Lutz R, Dedrik R, Boretos J, et al. Mixing studies during intracarotid arterial infusions in an in vitro model. J Neurosurg 1986;64:277-283.
22. Hochberg F, Pruitt A, Beck D, et al. The rationally and methodology for intra-arterial chemotherapy whith BCNU as treatment for glioblastoma multiform. J Neurosurg 1985;63:876-880.
23. Silvane A, Eoli M, Salmaggi A, et al. Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma. J Neurol Sci 2002;23:219-224.
24. Grossman SA, O'Neill A, Grunnet M, et al. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy and concurrent carmustine in patients with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Estern Cooperative Oncology Grooup Trial 2394. J Clin Oncol 2003;21:1485-1491.
25. Buckner JC, Ballman KV, Michalak JC, et al. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials. J Clin Oncol 2006;24:3871-3879.
26. Levin V, Kabra P, Freeman-Dove M. Pharmacokinetics of intracarotid artery 14-C BCNU in the squired Monkey. J Neurosurg 1978;48:587-593.
27. Stewart D, Grahovac Z, Hugenholtz H, et al. Combined intra-arterial and systemic chemotherapy for intracerebral tumors. Neurosurgery 1987;21: 207-214.
28. Saris S, Wright D, Oldfield E, et al. Intravascular streaming and variable delivery to brain following carotid artery infusions in the Sprague-Dawley rat. J Cereb Blood Flow 1988;8:116-120.
29. Rosenblum M, Delattre J, Shapiro W. Fatal necrotizing encephalopathy complicating treatment of malignant gliomas with intra-arterial BCNU and irradiation: a pathological study. J Neurooncol 1989;7:269-281.
30. Kapp JP, Ross RL, Tucker EM. Supraophthalmic carotid infusion for brain-tumor chemotherapy. Technical note. J Neurosurg 1983;58:616-618.
31. Saris S, Blasberg R, Carson R, et al. Intravascular streaming during carotid artery infusions. J Neurosurg 1991;74:763-772.
32. Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent malignant gliomas. The Polymer-Brain Tumor Treatment Group. Lancet 1995;345:1008-1012.
33. Westphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant gliomas. Neuro Oncol 2003;5:79-88.